In 2017, the FDA approved Radicava, a drug that prevents nerve damage and slows ALS progression. Five years later, Relyvrio, which prevents nerve cell death by blocking stress signals in cells ...

helped inspire a viral social media movement that has had tangible effects on those living with ALS and those who will be diagnosed in the future. "Here we are five years later, you dumped water ...